Premier Biomedical, Inc.

BIEI

US74048K2033

Specialty Chemicals

Market Closed - OTC Markets Other stock markets 03:12:40 2024-05-03 pm EDT			5-day change	1st Jan Change
0.0016 ^USD	+23.08%		+23.08%	+77.78%

Mar. 07	Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	CI
2022	Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	CI

PREMIER BIOMEDICAL INC : Financial Statements and Exhibits (form 8-K)

May 14, 2020 at 01:10 pm EDT

Item 9.01 Financial Statements and Exhibits.



(d)
Exhibits

  10.1        Technology Acquisition and Financing Agreement dated May 8, 2020

  10.2        Intellectual Property Agreement dated May 12, 2020

  10.3        Third Addendum to License Agreement with Marv Enterprises, LLC dated May
              11, 2020

Latest news about Premier Biomedical, Inc.

Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	Mar. 07	CI
Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	22-12-20	CI
Itaú Unibanco S A : Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine factory	20-08-07	RE
William A. Hartman Resigns as Chief Executive Officer of Premier Biomedical, Inc	20-06-01	CI
Heidi H. Carl Resigns as Chief Financial Officer of Premier Biomedical, Inc	20-06-01	CI
Premier Biomedical, Inc. Announces Executive Changes	20-06-01	CI
Premier Biomedical, Inc. Appoints David Caplan to the Board of Directors	20-06-01	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-15	CI
Premier Biomedical, Inc. Announces Resignation of Mitchell Felder as Chairman and Member of Board of Directors	20-05-07	CI
Premier Biomedical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Premier Biomedical, Inc. announced that it has received $0.025 million in funding from Green Coast Capital International S.A.	19-10-02	CI
Premier Biomedical, Inc. announced that it expects to receive $5 million in funding from Green Coast Capital International S.A.	19-09-25	CI
Premier Biomedical, Inc. announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	19-08-15	CI
Premier Biomedical, Inc. announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd.	19-08-14	CI
Premier Biomedical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-08-06	CI
Premier Biomedical, Inc. Announces Joint Venture with New Earth Development Corporation, Rushnet, Inc., and XYZ Hemp, Inc	19-08-06	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	19-08-01	CI
Premier Biomedical, Inc. Announces Signing of an Agreement Forming a Joint Venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc	19-07-29	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-06-11	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	19-06-06	CI
Premier Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-15	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-04-22	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-15	CI
Premier Biomedical, Inc. announced that it has received $0.068 million in funding from PowerUp Lending Group, Ltd.	19-03-27	CI

Chart Premier Biomedical, Inc.

Duration

Period

More charts

Premier Graphene, Inc. is a global advanced materials firm with a focus on research, production and marketing of eco-friendly graphene. The Companyâs graphene and novel additive formulations are integrated into the production process of other products. The Company is engaged in supplying large-scale industrial quantities. Its proprietary graphene blends and formulations target specific product enhancements sought by manufacturers.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
PREMIER BIOMEDICAL, INC.	+77.78%	1.76M
ECOLAB INC.	+14.70%	65.04B
SIKA AG	-1.61%	47.76B
GIVAUDAN SA	+14.58%	40.72B
FUJIFILM HOLDINGS CORPORATION	+20.84%	26.88B
EMS-CHEMIE HOLDING AG	+9.54%	19.29B
CELANESE CORPORATION	+1.16%	17.53B
POSCO FUTURE M CO., LTD.	-21.87%	16.03B
SYMRISE AG	+1.11%	15.17B
ALBEMARLE CORPORATION	-11.34%	15.06B

Other Specialty Chemicals